baker-ms

baker-ms

Macquarie University

H-index: 54

Oceania-Australia

About baker-ms

baker-ms, With an exceptional h-index of 54 and a recent h-index of 30 (since 2020), a distinguished researcher at Macquarie University,

His recent articles reflect a diverse array of research interests and contributions to the field:

Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4/5 variants in patients with inflammatory bowel disease treated with infliximab and …

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

A second update on mapping the human genetic architecture of COVID-19

Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF …

baker-ms Information

University

Position

___

Citations(all)

10163

Citations(since 2020)

3973

Cited By

7607

hIndex(all)

54

hIndex(since 2020)

30

i10Index(all)

156

i10Index(since 2020)

75

Email

University Profile Page

Macquarie University

Google Scholar

View Google Scholar Profile

Top articles of baker-ms

Title

Journal

Author(s)

Publication Date

Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management

Aziz AA Alnakli

Abidali Mohamedali

Benjamin Heng

Charles Chan

Joo-Shik Shin

...

2024/2/13

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised …

The Lancet Child & Adolescent Health

Saul N Faust

Richard Haynes

Christine E Jones

Natalie Staplin

Elizabeth Whittaker

...

2024/3/1

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA. 1 and BA. 4/5 variants in patients with inflammatory bowel disease treated with infliximab and …

The Lancet Gastroenterology & Hepatology

Zhigang Liu

Kaixing Le

Xin Zhou

James L Alexander

Simeng Lin

...

2023/2/1

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Diabetes & Endocrinology

O Abani

A Abbas

F Abbas

J Abbas

K Abbas

...

2023/12/1

A second update on mapping the human genetic architecture of COVID-19

Nature

Masahiro Kanai

Shea J Andrews

Mattia Cordioli

Christine Stevens

Benjamin M Neale

...

2023/9/7

Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma

Molecular Therapy

Nitin Chitranshi

Rashi Rajput

Angela Godinez

Kanishka Pushpitha

Mehdi Mirzaei

...

2023/7/5

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open …

The Lancet

Obbina Abani

Ali Abbas

Fatima Abbas

Joshua Abbas

Kasim Abbas

...

2023/5/6

Implications for sequencing of biologic therapy and choice of second anti‐TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti‐TNF …

Alimentary Pharmacology & Therapeutics

Neil Chanchlani

Simeng Lin

Marcus K Auth

Chai Leng Lee

Helena Robbins

...

2022/10

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

The Lancet

Obbina Abani

Ali Abbas

Fatima Abbas

Joshua Abbas

Kasim Abbas

...

2022/7/30

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Medrxiv

RECOVERY Collaborative Group

Peter W Horby

Marion Mafham

Leon Peto

Mark Campbell

...

2021/6/16

Use of a recombinant biomarker protein DDA library increases DIA coverage of low abundance plasma proteins

Journal of proteome research

Seong Beom Ahn

Karthik S Kamath

Abidali Mohamedali

Zainab Noor

Jemma X Wu

...

2021/3/22

Mass spectrometry–based protein identification in proteomics—a review

Zainab Noor

Seong Beom Ahn

Mark S Baker

Shoba Ranganathan

Abidali Mohamedali

2021/3

Role of multiomics data to understand host–pathogen interactions in COVID-19 pathogenesis

Journal of Proteome Research

Shalini Aggarwal

Arup Acharjee

Amrita Mukherjee

Mark S Baker

Sanjeeva Srivastava

2021/1/11

Sub-genic intolerance, ClinVar, and the epilepsies: A whole-exome sequencing study of 29,165 individuals

The American Journal of Human Genetics

Joshua E Motelow

Gundula Povysil

Ryan S Dhindsa

Kate E Stanley

Andrew S Allen

...

2021/6/3

Research on the human proteome reaches a major milestone:> 90% of predicted human proteins now credibly detected, according to the HUPO human proteome project

Journal of proteome research

Gilbert S Omenn

Lydie Lane

Christopher M Overall

Ileana M Cristea

Fernando J Corrales

...

2020/9/15

Fibrinolysis and the immune response in trauma

Robert L Medcalf

Charithani B Keragala

Dominik F Draxler

2020/3

A Recombinant Protein Biomarker DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins

bioRxiv

Seong Beom Ahn

Karthik S Kamath

Abidali Mohamedali

Zainab Noor

Jemma X Wu

...

2020/11/12

A high-stringency blueprint of the human proteome

Subash Adhikari

Edouard C Nice

Eric W Deutsch

Lydie Lane

Gilbert S Omenn

...

2020/10/16

See List of Professors in baker-ms University(Macquarie University)